**Codes and applicable crosswalks are preliminary. Official codes will be available on code effective date shown below. Information pulled from Encoderpro.com.
| Code | Description | Reference | Edits | Effective Date |
|---|---|---|---|---|
| C78.31 | Secondary malignant neoplasm of larynx |  | 10/01/2026 | |
| C78.32 | Secondary malignant neoplasm of pharynx | | 10/01/2026 | |
| C79.83 | Secondary malignant neoplasm of oral cavity | | 10/01/2026 | |
| D69.11 | Glanzmann thrombasthenia | | 10/01/2026 | |
| D69.19 | Other qualitative platelet defects | | 10/01/2026 | |
| E89.830 | Post bariatric hypoglycemia | | 10/01/2026 | |
| E89.838 | Other postprocedural hypoglycemia | | 10/01/2026 | |
| F64.A | Gender identity disorder, in remission | | 10/01/2026 | |
| I42.00 | Dilated cardiomyopathy, unspecified | | 10/01/2026 | |
| I42.01 | Familial-genetic dilated cardiomyopathy | | 10/01/2026 | |
| I42.09 | Other dilated cardiomyopathy | | 10/01/2026 | |
| I42.81 | Arrhythmogenic cardiomyopathy | | 10/01/2026 | |
| I42.89 | Other cardiomyopathies not elsewhere classified | | 10/01/2026 | |
| I47.22 | Catecholaminergic polymorphic ventricular tachycardia [CPVT] | | 10/01/2026 | |
| I49.81 | Brugada syndrome | | 10/01/2026 | |
| I49.82 | Ventricular bigeminy | | 10/01/2026 | |
| I49.89 | Other specified cardiac arrhythmias not elsewhere classified | | 10/01/2026 | |
| J34.830 | Odontogenic sinusitis, maxillary sinus | | 10/01/2026 | |
| J34.831 | Odontogenic sinusitis, ethmoid sinus | | 10/01/2026 | |
| J34.832 | Odontogenic sinusitis, frontal sinus | | 10/01/2026 | |
| J34.833 | Odontogenic sinusitis, sphenoid sinus | | 10/01/2026 | |
| J34.839 | Odontogenic sinusitis, unspecified | | 10/01/2026 | |
| J4B | Pulmonary mycetoma | | 10/01/2026 | |
| K31.B | Hypertrophic pyloric stenosis, in childhood | | 10/01/2026 | |
| K6A.01 | Prevesical abscess | | 10/01/2026 | |
| K6A.09 | Other pelvic abscess | | 10/01/2026 | |
| K6A.8 | Other diseases of the pelvis, not elsewhere classified | | 10/01/2026 | |
| K74.0A | Hepatic fibrosis, moderate fibrosis | | 10/01/2026 | |
| K76.83 | Intestinal failure-associated liver disease | | 10/01/2026 | |
| L02.237 | Carbuncle of flank | | 10/01/2026 | |
| M04.3 | VEXAS syndrome | | 10/01/2026 | |
| M67.A01 | Plantar fasciitis, right foot | | 10/01/2026 | |
| M67.A02 | Plantar fasciitis, left foot | | 10/01/2026 | |
| M67.A09 | Plantar fasciitis, unspecified foot | | 10/01/2026 | |
| M72.20 | Plantar fascial fibromatosis, unspecified foot | | 10/01/2026 | |
| M72.21 | Plantar fascial fibromatosis, right foot | | 10/01/2026 | |
| M72.22 | Plantar fascial fibromatosis, left foot | | 10/01/2026 | |
| M86.8X11 | Other osteomyelitis, right shoulder | | 10/01/2026 | |
| M86.8X12 | Other osteomyelitis, left shoulder | | 10/01/2026 | |
| M86.8X19 | Other osteomyelitis, unspecified shoulder | | 10/01/2026 | |
| M86.8X21 | Other osteomyelitis, right upper arm | | 10/01/2026 | |
| M86.8X22 | Other osteomyelitis, left upper arm | | 10/01/2026 | |
| M86.8X29 | Other osteomyelitis, unspecified upper arm | | 10/01/2026 | |
| M86.8X31 | Other osteomyelitis, right forearm | | 10/01/2026 | |
| M86.8X32 | Other osteomyelitis, left forearm | | 10/01/2026 | |
| M86.8X39 | Other osteomyelitis, unspecified forearm | | 10/01/2026 | |
| M86.8X41 | Other osteomyelitis, right hand | | 10/01/2026 | |
| M86.8X42 | Other osteomyelitis, left hand | | 10/01/2026 | |
| M86.8X49 | Other osteomyelitis, unspecified hand | | 10/01/2026 | |
| M86.8X51 | Other osteomyelitis, right thigh | | 10/01/2026 | |
| M86.8X52 | Other osteomyelitis, left thigh | | 10/01/2026 | |
| M86.8X59 | Other osteomyelitis, unspecified thigh | | 10/01/2026 | |
| M86.8X61 | Other osteomyelitis, right lower leg | | 10/01/2026 | |
| M86.8X62 | Other osteomyelitis, left lower leg | | 10/01/2026 | |
| M86.8X69 | Other osteomyelitis, unspecified lower leg | | 10/01/2026 | |
| M86.8X71 | Other osteomyelitis, right ankle and foot | | 10/01/2026 | |
| M86.8X72 | Other osteomyelitis, left ankle and foot | | 10/01/2026 | |
| M86.8X79 | Other osteomyelitis, unspecified ankle and foot | | 10/01/2026 | |
| M86.8X80 | Other osteomyelitis, skull | | 10/01/2026 | |
| M86.8X81 | Other osteomyelitis, face and sinuses | | 10/01/2026 | |
| M86.8X89 | Other osteomyelitis, other site | | 10/01/2026 | |
| N99.860 | Intraoperative and postprocedural nipple ischemia | | 10/01/2026 | |
| N99.861 | Intraoperative and postprocedural nipple necrosis | | 10/01/2026 | |
| O00.121 | Right interstitial ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.122 | Left interstitial ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.129 | Unspecified interstitial ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.131 | Right interstitial ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O00.132 | Left interstitial ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O00.139 | Unspecified interstitial ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O00.31 | Cesarean scar ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.32 | Cesarean scar ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O00.41 | Cervical ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.42 | Cervical ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O00.511 | Right cornual ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.512 | Left cornual ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.519 | Unspecified cornual ectopic pregnancy without intrauterine pregnancy | | 10/01/2026 | |
| O00.521 | Right cornual ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O00.522 | Left cornual ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O00.529 | Unspecified cornual ectopic pregnancy with intrauterine pregnancy | | 10/01/2026 | |
| O31.40X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, not applicable or unspecified | | 10/01/2026 | |
| O31.40X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 1 | | 10/01/2026 | |
| O31.40X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 2 | | 10/01/2026 | |
| O31.40X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 3 | | 10/01/2026 | |
| O31.40X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 4 | | 10/01/2026 | |
| O31.40X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, fetus 5 | | 10/01/2026 | |
| O31.40X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, unspecified trimester, other fetus | | 10/01/2026 | |
| O31.41X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, not applicable or unspecified | | 10/01/2026 | |
| O31.41X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 1 | | 10/01/2026 | |
| O31.41X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 2 | | 10/01/2026 | |
| O31.41X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 3 | | 10/01/2026 | |
| O31.41X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 4 | | 10/01/2026 | |
| O31.41X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, fetus 5 | | 10/01/2026 | |
| O31.41X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, first trimester, other fetus | | 10/01/2026 | |
| O31.42X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, not applicable or unspecified | | 10/01/2026 | |
| O31.42X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 1 | | 10/01/2026 | |
| O31.42X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 2 | | 10/01/2026 | |
| O31.42X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 3 | | 10/01/2026 | |
| O31.42X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 4 | | 10/01/2026 | |
| O31.42X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, fetus 5 | | 10/01/2026 | |
| O31.42X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, second trimester, other fetus | | 10/01/2026 | |
| O31.43X0 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, not applicable or unspecified | | 10/01/2026 | |
| O31.43X1 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 1 | | 10/01/2026 | |
| O31.43X2 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 2 | | 10/01/2026 | |
| O31.43X3 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 3 | | 10/01/2026 | |
| O31.43X4 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 4 | | 10/01/2026 | |
| O31.43X5 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, fetus 5 | | 10/01/2026 | |
| O31.43X9 | Continuing pregnancy after vanishing twin syndrome of one fetus or more, third trimester, other fetus | | 10/01/2026 | |
| Q87.A | Loeys-Dietz syndrome | | 10/01/2026 | |
| QA1.71 | Lynch syndrome | | 10/01/2026 | |
| QA1.790 | Familial cancer syndrome with pathogenic BRCA1 mutation | | 10/01/2026 | |
| QA1.791 | Familial cancer syndrome with pathogenic BRCA2 mutation | | 10/01/2026 | |
| QA1.792 | Li Fraumeni syndrome | | 10/01/2026 | |
| QA1.798 | Other inherited neoplasm predisposition syndrome of multiple systems | | 10/01/2026 | |
| R78.72 | Abnormal gadolinium level in blood | | 10/01/2026 | |
| T52.811A | Toxic effect of alkenes, accidental (unintentional), initial encounter | | 10/01/2026 | |
| T52.811D | Toxic effect of alkenes, accidental (unintentional), subsequent encounter | | 10/01/2026 | |
| T52.811S | Toxic effect of alkenes, accidental (unintentional), sequela | | 10/01/2026 | |
| T52.812A | Toxic effect of alkenes, intentional self-harm, initial encounter | | 10/01/2026 | |
| T52.812D | Toxic effect of alkenes, intentional self-harm, subsequent encounter | | 10/01/2026 | |
| T52.812S | Toxic effect of alkenes, intentional self-harm, sequela | | 10/01/2026 | |
| T52.813A | Toxic effect of alkenes, assault, initial encounter | | 10/01/2026 | |
| T52.813D | Toxic effect of alkenes, assault, subsequent encounter | | 10/01/2026 | |
| T52.813S | Toxic effect of alkenes, assault, sequela | | 10/01/2026 | |
| T52.814A | Toxic effect of alkenes, undetermined, initial encounter | | 10/01/2026 | |
| T52.814D | Toxic effect of alkenes, undetermined, subsequent encounter | | 10/01/2026 | |
| T52.814S | Toxic effect of alkenes, undetermined, sequela | | 10/01/2026 | |
| T52.821A | Toxic effect of cycloparaffins, accidental (unintentional), initial encounter | | 10/01/2026 | |
| T52.821D | Toxic effect of cycloparaffins, accidental (unintentional), subsequent encounter | | 10/01/2026 | |
| T52.821S | Toxic effect of cycloparaffins, accidental (unintentional), sequela | | 10/01/2026 | |
| T52.822A | Toxic effect of cycloparaffins, intentional self-harm, initial encounter | | 10/01/2026 | |
| T52.822D | Toxic effect of cycloparaffins, intentional self-harm, subsequent encounter | | 10/01/2026 | |
| T52.822S | Toxic effect of cycloparaffins, intentional self-harm, sequela | | 10/01/2026 | |
| T52.823A | Toxic effect of cycloparaffins, assault, initial encounter | | 10/01/2026 | |
| T52.823D | Toxic effect of cycloparaffins, assault, subsequent encounter | | 10/01/2026 | |
| T52.823S | Toxic effect of cycloparaffins, assault, sequela | | 10/01/2026 | |
| T52.824A | Toxic effect of cycloparaffins, undetermined, initial encounter | | 10/01/2026 | |
| T52.824D | Toxic effect of cycloparaffins, undetermined, subsequent encounter | | 10/01/2026 | |
| T52.824S | Toxic effect of cycloparaffins, undetermined, sequela | | 10/01/2026 | |
| T52.891A | Toxic effect of other organic solvents, accidental (unintentional), initial encounter | | 10/01/2026 | |
| T52.891D | Toxic effect of other organic solvents, accidental (unintentional), subsequent encounter | | 10/01/2026 | |
| T52.891S | Toxic effect of other organic solvents, accidental (unintentional), sequela | | 10/01/2026 | |
| T52.892A | Toxic effect of other organic solvents, intentional self-harm, initial encounter | | 10/01/2026 | |
| T52.892D | Toxic effect of other organic solvents, intentional self-harm, subsequent encounter | | 10/01/2026 | |
| T52.892S | Toxic effect of other organic solvents, intentional self-harm, sequela | | 10/01/2026 | |
| T52.893A | Toxic effect of other organic solvents, assault, initial encounter | | 10/01/2026 | |
| T52.893D | Toxic effect of other organic solvents, assault, subsequent encounter | | 10/01/2026 | |
| T52.893S | Toxic effect of other organic solvents, assault, sequela | | 10/01/2026 | |
| T52.894A | Toxic effect of other organic solvents, undetermined, initial encounter | | 10/01/2026 | |
| T52.894D | Toxic effect of other organic solvents, undetermined, subsequent encounter | | 10/01/2026 | |
| T52.894S | Toxic effect of other organic solvents, undetermined, sequela | | 10/01/2026 | |
| T59.821A | Toxic effect of hexamethylene diisocyanate, accidental (unintentional), initial encounter | | 10/01/2026 | |
| T59.821D | Toxic effect of hexamethylene diisocyanate, accidental (unintentional), subsequent encounter | | 10/01/2026 | |
| T59.821S | Toxic effect of hexamethylene diisocyanate, accidental (unintentional), sequela | | 10/01/2026 | |
| T59.822A | Toxic effect of hexamethylene diisocyanate, intentional self-harm, initial encounter | | 10/01/2026 | |
| T59.822D | Toxic effect of hexamethylene diisocyanate, intentional self-harm, subsequent encounter | | 10/01/2026 | |
| T59.822S | Toxic effect of hexamethylene diisocyanate, intentional self-harm, sequela | | 10/01/2026 | |
| T59.823A | Toxic effect of hexamethylene diisocyanate, assault, initial encounter | | 10/01/2026 | |
| T59.823D | Toxic effect of hexamethylene diisocyanate, assault, subsequent encounter | | 10/01/2026 | |
| T59.823S | Toxic effect of hexamethylene diisocyanate, assault, sequela | | 10/01/2026 | |
| T59.824A | Toxic effect of hexamethylene diisocyanate, undetermined, initial encounter | | 10/01/2026 | |
| T59.824D | Toxic effect of hexamethylene diisocyanate, undetermined, subsequent encounter | | 10/01/2026 | |
| T59.824S | Toxic effect of hexamethylene diisocyanate, undetermined, sequela | | 10/01/2026 | |
| T65.851A | Toxic effect of medetomidine, accidental (unintentional), initial encounter | | 10/01/2026 | |
| T65.851D | Toxic effect of medetomidine, accidental (unintentional), subsequent encounter | | 10/01/2026 | |
| T65.851S | Toxic effect of medetomidine, accidental (unintentional), sequela | | 10/01/2026 | |
| T65.852A | Toxic effect of medetomidine, intentional self-harm, initial encounter | | 10/01/2026 | |
| T65.852D | Toxic effect of medetomidine, intentional self-harm, subsequent encounter | | 10/01/2026 | |
| T65.852S | Toxic effect of medetomidine, intentional self-harm, sequela | | 10/01/2026 | |
| T65.853A | Toxic effect of medetomidine, assault, initial encounter | | 10/01/2026 | |
| T65.853D | Toxic effect of medetomidine, assault, subsequent encounter | | 10/01/2026 | |
| T65.853S | Toxic effect of medetomidine, assault, sequela | | 10/01/2026 | |
| T65.854A | Toxic effect of medetomidine, undetermined, initial encounter | | 10/01/2026 | |
| T65.854D | Toxic effect of medetomidine, undetermined, subsequent encounter | | 10/01/2026 | |
| T65.854S | Toxic effect of medetomidine, undetermined, sequela | | 10/01/2026 | |
| Z68.18 | Body mass index [BMI] 18.4 or less, adult | | 10/01/2026 | |
| Z68.19 | Body mass index [BMI] 18.5-19.9, adult | | 10/01/2026 | |
| Z77.013 | Contact with and (suspected) exposure to gadolinium | | 10/01/2026 | |
| Z77.32 | Contact with and (suspected) exposure to burn pits in war theater | | 10/01/2026 | |
| Z77.33 | Contact with and (suspected) exposure to Agent Orange | | 10/01/2026 | |
| Z77.40 | Contact with and (suspected) exposure to unspecified blast overpressure | | 10/01/2026 | |
| Z77.41 | Contact with and (suspected) exposure to low-level blast overpressure | | 10/01/2026 | |
| Z77.42 | Contact with and (suspected) exposure to high-level blast overpressure | | 10/01/2026 | |
| Z77.49 | Contact with and (suspected) exposure to other blast overpressure | | 10/01/2026 | |
| Z86.17 | Personal history of Clostridioides difficile infection | | 10/01/2026 | |
| Z87.8901 | Personal history of social gender transition | | 10/01/2026 | |
| Z87.8902 | Personal history of medical gender transition | | 10/01/2026 | |
| Z87.8903 | Personal history of surgical gender transition | | 10/01/2026 | |
| Z87.8904 | Personal history of intersex surgery | | 10/01/2026 | |
| Z87.8909 | Personal history of unspecified gender transition | | 10/01/2026 | |
| Z87.893 | Personal history of gender detransition | | 10/01/2026 |